References
M.D. Ringel, F. Nabhan, Approach to follow-up of the patient with differentiated thyroid cancer and positive anti-thyroglobulin antibodies. J. Clin. Endocrinol. Metab. 98(8), 3104–3110 (2013)
F. Latrofa, D. Ricci, L. Montanelli et al., Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin. J. Clin. Endocrinol. Metab. 97(7), 2380–2387 (2012)
F. Latrofa, D. Ricci, L. Montanelli et al., Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. J. Clin. Endocrinol. Metab. 97(11), 3974–3982 (2012)
C. Spencer, I. Petrovic, S. Fatemi, Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 96(5), 1283–1291 (2011)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Loh, T.P., Chong, H.W. & Kao, S.L. Thyroglobulin and thyroglobulin autoantibodies: interpret with care. Endocrine 46, 360–361 (2014). https://doi.org/10.1007/s12020-013-0103-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-0103-z